Reports for TEVA-ABACAVIR/LAMIVUDINE
Brand name
TEVA-ABACAVIR/LAMIVUDINE
Company Name
TEVA CANADA LIMITED
|
Drug Identification Number
02416662 |
Ingredients
LAMIVUDINE ABACAVIR |
Ingredient Strength
300 MG 600 MG |
ATC Code
J05AR |
ATC Descriptor
DIRECT ACTING ANTIVIRALS |
Status
MARKETED
|
Shortage reports
Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|
TEVA-ABACAVIR/LAMIVUDINE | 30 | Resolved | 2021-10-21 | 2021-12-17 | 147699 |
TEVA-ABACAVIR/LAMIVUDINE | 100 | Resolved | 2022-08-18 | 2022-12-22 | 167237 |
TEVA-ABACAVIR/LAMIVUDINE | 100, 30 | Resolved | 2023-06-08 | 2023-07-05 | 194180 |
TEVA-ABACAVIR/LAMIVUDINE | 100 | Resolved | 2023-06-16 | 2023-08-17 | 195072 |
TEVA-ABACAVIR/LAMIVUDINE | 300MG | Resolved | 2023-06-20 | 2023-08-18 | 195900 |
Showing 1 to 5 of 5
Discontinuation reports
Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
---|
Showing 1 to 0 of 0